CS332591A3 - 1-(2-arylethyl)pyrrolidines, process of their preparation and pharmaceuticals prepared on the base thereof - Google Patents
1-(2-arylethyl)pyrrolidines, process of their preparation and pharmaceuticals prepared on the base thereofInfo
- Publication number
- CS332591A3 CS332591A3 CS913325A CS332591A CS332591A3 CS 332591 A3 CS332591 A3 CS 332591A3 CS 913325 A CS913325 A CS 913325A CS 332591 A CS332591 A CS 332591A CS 332591 A3 CS332591 A3 CS 332591A3
- Authority
- CS
- Czechoslovakia
- Prior art keywords
- arylethyl
- pyrrolidines
- preparation
- base
- pharmaceuticals prepared
- Prior art date
Links
- 239000003814 drug Substances 0.000 title 1
- 150000003235 pyrrolidines Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/08—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
- C07D207/09—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/08—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/12—Oxygen or sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pain & Pain Management (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyrrole Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE4034785A DE4034785A1 (de) | 1990-11-02 | 1990-11-02 | 1-(2-arylethyl)-pyrrolidine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CS332591A3 true CS332591A3 (en) | 1992-05-13 |
Family
ID=6417469
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CS913325A CS332591A3 (en) | 1990-11-02 | 1991-11-01 | 1-(2-arylethyl)pyrrolidines, process of their preparation and pharmaceuticals prepared on the base thereof |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP0483580A3 (cs) |
| JP (1) | JPH04264067A (cs) |
| KR (1) | KR920009791A (cs) |
| AU (1) | AU8553891A (cs) |
| CA (1) | CA2054648A1 (cs) |
| CS (1) | CS332591A3 (cs) |
| DE (1) | DE4034785A1 (cs) |
| HU (1) | HUT61727A (cs) |
| PT (1) | PT99383A (cs) |
| ZA (1) | ZA918716B (cs) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4215213A1 (de) * | 1992-05-09 | 1993-11-11 | Merck Patent Gmbh | Arylacetamide |
| WO1994018165A1 (en) * | 1993-02-12 | 1994-08-18 | Pfizer Inc. | Sulfonamide compounds as opioid k-receptor agonists |
| WO1996006078A1 (en) * | 1994-08-24 | 1996-02-29 | Pfizer Pharmaceuticals Inc. | N-(2-(pyrrolidinyl-1)-1-phenylethyl)acetamides as kappa receptor antagonists |
| DE19523502A1 (de) * | 1995-06-28 | 1997-01-02 | Merck Patent Gmbh | Kappa-Opiatagonisten für entzündliche Darmerkrankungen |
| DE19531464A1 (de) * | 1995-08-26 | 1997-02-27 | Merck Patent Gmbh | N-Methyl-N-[(1S-)-1-phenyl-2-((3S)-3-hydroxypyrrolidin 1-yl-)-ethyl]-2,2-diphenyl-acetamid |
| MX9701042A (es) | 1996-02-07 | 1998-05-31 | Pfizer | Compuestos del acido hidroxamico. |
| US6239154B1 (en) | 1996-03-08 | 2001-05-29 | Adolor Corporation | Kappa agonist compounds pharmaceutical formulations and method of prevention and treatment of pruritus therewith |
| US6303611B1 (en) * | 1996-03-08 | 2001-10-16 | Adolor Corporation | Kappa agonist compounds and pharmaceutical formulations thereof |
| US5763445A (en) | 1996-03-08 | 1998-06-09 | Adolor Corporation | Kappa agonist compounds pharmaceutical formulations and method of prevention and treatment of pruritus therewith |
| US5646151A (en) * | 1996-03-08 | 1997-07-08 | Adolor Corporation | Kappa agonist compounds and pharmaceutical formulations thereof |
| TNSN97092A1 (ar) | 1996-09-18 | 1999-12-31 | Agouron Pharma | مثبطات انزيم بروتيني فلزي وتركيبات صيدلانية تحتوي على تلك المثبتطات واستخدامها الصيدلاني وطرق ومركبات وسيطة مفيدة لتحضير التركيبات المذكورة. |
| US5760023A (en) * | 1997-07-14 | 1998-06-02 | Adolor Corporation | Kappa agonist anti-pruritic pharmaceutical formulations and method of treating pruritus therewith |
| CA2288828A1 (en) * | 1997-07-14 | 1999-01-28 | Adolor Corporation | Kappa agonist anti-pruritic pharmaceutical formulations and method of treating pruritus therewith |
| DE19827633A1 (de) * | 1998-04-20 | 1999-10-21 | Merck Patent Gmbh | Verfahren zur Herstellung von enantiomerenreinem N-Methyl-N-[(1S)-1-phenyl-2-((3S)-3-hydroxypyrrolidin-1-yl)ethyl]-2,2-diphenylacetamid |
| EP0982297A3 (en) * | 1998-08-24 | 2001-08-01 | Pfizer Products Inc. | Process for the preparation of hydroxy-pyrrolidinyl hydroxamic acid derivatives being opioid kappa receptor agonists |
| AU2002247886A1 (en) | 2001-04-30 | 2002-11-11 | Pfizer Products Inc. | Process for preparing hydroxypyrrolidinyl ethylamine compounds useful as kappa agonists |
| CN100411618C (zh) | 2002-05-17 | 2008-08-20 | 迪欧加药品公司 | 有效的选择性阿片受体调制剂化合物的用途 |
| US6992193B2 (en) | 2003-06-10 | 2006-01-31 | Adolor Corporation | Sulfonylamino phenylacetamide derivatives and methods of their use |
| DE10331723A1 (de) * | 2003-07-11 | 2005-06-16 | Merck Patent Gmbh | Kappa-Agonisten |
| EP2636407A3 (en) | 2007-03-30 | 2013-11-06 | Tioga Pharmaceuticals, Inc. | Kappa-opiate agonists for the treatment of diarrhea-predominant and alternating irritable bowel syndrome |
| JP5779100B2 (ja) | 2008-11-24 | 2015-09-16 | カウンシル オブ サイエンティフィック アンド インダストリアル リサーチ | 光学的に活性なｎ−ベンジル−３−ヒドロキシピロリジンの製造方法 |
| JP6138169B2 (ja) * | 2012-03-05 | 2017-05-31 | ドクター レディズ ラボラトリーズ リミテッド | κオピオイド受容体（ＫＯＲ）アゴニストとしての置換複素環式アセトアミド |
| JP6665189B2 (ja) * | 2014-12-23 | 2020-03-13 | ネクター セラピューティクス | κオピオイド受容体に対するＮ−メチル−Ｎ−（１−フェニル−２−（１−ピロリジニル）エチル）−２−アミノフェニルアセトアミド誘導体作動薬 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AT376669B (de) * | 1982-11-26 | 1984-12-27 | Laevosan Gmbh & Co Kg | Verfahren zur herstellung neuer thienylessigsaeureamid-derivate und pharmazeutisch vertraeglicher saeureadditionssalze davon |
| GB8618188D0 (en) * | 1986-07-25 | 1986-09-03 | Ici Plc | Diamine compounds |
| EP0261842B1 (en) * | 1986-09-17 | 1990-11-22 | Dr. Lo. Zambeletti S.p.A. | N1-acylated-(1-(phenyl or benzyl))-1,2-ethylene diamines |
| DE3935371A1 (de) * | 1988-12-23 | 1990-07-05 | Merck Patent Gmbh | Stickstoffhaltige ringverbindungen |
-
1990
- 1990-11-02 DE DE4034785A patent/DE4034785A1/de not_active Withdrawn
-
1991
- 1991-10-02 AU AU85538/91A patent/AU8553891A/en not_active Abandoned
- 1991-10-14 EP EP19910117502 patent/EP0483580A3/de not_active Withdrawn
- 1991-10-30 PT PT99383A patent/PT99383A/pt not_active Application Discontinuation
- 1991-10-31 CA CA002054648A patent/CA2054648A1/en not_active Abandoned
- 1991-11-01 CS CS913325A patent/CS332591A3/cs unknown
- 1991-11-01 JP JP3313182A patent/JPH04264067A/ja active Pending
- 1991-11-01 HU HU913448A patent/HUT61727A/hu unknown
- 1991-11-01 ZA ZA918716A patent/ZA918716B/xx unknown
- 1991-11-01 KR KR1019910019396A patent/KR920009791A/ko not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| JPH04264067A (ja) | 1992-09-18 |
| DE4034785A1 (de) | 1992-05-07 |
| EP0483580A3 (en) | 1992-09-02 |
| PT99383A (pt) | 1992-09-30 |
| KR920009791A (ko) | 1992-06-25 |
| CA2054648A1 (en) | 1992-05-03 |
| HU913448D0 (en) | 1992-01-28 |
| ZA918716B (en) | 1992-08-26 |
| HUT61727A (en) | 1993-03-01 |
| AU8553891A (en) | 1992-05-07 |
| EP0483580A2 (de) | 1992-05-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL98472A0 (en) | Dialkoxy-pyridinyl-benzimidazole derivatives,process for their preparation and their pharmaceutical use | |
| AU3305989A (en) | 1,3-disubstituted pyrrolidines | |
| HUT64734A (en) | Anthraquinone-derivativdes, process for preparing them and pharmaceutical compositions containing them | |
| ZA914296B (en) | Dialkoxy-pyridinyl-benzimidazole derivatives,process for their preparation and their pharmaceutical use | |
| EP0429341A3 (en) | Heterocyclic derivatives, their preparation and pharmaceuticals containing them | |
| NZ238552A (en) | Benzodiazepin-2-amine derivatives; preparatory processes, use, and medicaments | |
| HU913448D0 (en) | 1-(2-arylethyl)-pyrrholidines and process for their production and the medical preparations containing them | |
| LTIP709A (en) | Sbstituted corticoid-17-alkylcarbonates, process for preparing thereof and pharmaceutical preparations | |
| HUT47956A (en) | Process for producing 2,3-disubstituted izoxazolidines and pharmaceuticals comprising same | |
| GB8924286D0 (en) | Pharmaceutical composition and process for preparing the same | |
| HU9202864D0 (en) | Gycinamide derivatives, their production and pharmaceutical preparatives containing them | |
| NO952205D0 (no) | Heterocykliske karbamater, fremgangsmåte for fremstilling derav og medikamenter | |
| ZA903409B (en) | Maleinimide-derivatives and their use as pharmaceuticals | |
| AU648105B2 (en) | Chromogenic lactam compounds, their preparation and their use | |
| CS265391A3 (en) | Novel thienodiazepines, process for their preparation and pharmaceutical comprising them | |
| FI903818A7 (fi) | 1-(pyridinyyliamino)-2-pyrrolidoneja, menetelmä niiden valmistamiseksija niiden käyttö lääkkeinä | |
| EP0543263A3 (en) | Benziimidazoles, pharmaceuticals containing them and process for their preparation | |
| GB9025509D0 (en) | New amide derivatives,processes for the preparation thereof and pharmaceutical composition comprising the same | |
| HRP931016A2 (en) | Thienothiazin derivatives, process for the preparation and application thereof | |
| NZ239105A (en) | Substituted diphenylmethylpiperazine derivatives; medicaments and preparatory processes | |
| HUT67605A (en) | 1-(4-oxo-thiazolidin-2-yliden)-thiosemicarbazide derivatives, pharmaceutical preparations containing them and process for producing them | |
| IL86173A (en) | Pyrrolidine derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same | |
| EP0473267A3 (en) | Acylaminopyridinecarboxamides, process for their preparation and their use as fungicides | |
| GB9124492D0 (en) | Hoof hardeners,waterproofers and methods | |
| AU6148090A (en) | N-(dialkyloxophosphinylalkyl)-lactams, process for preparing them and drugs containing them |